Increasing Prevalence of Autoimmune Diseases to Augment the Remicade Biosimilars Market Growth
Biosimilar is a bio-therapeutic drug that is similar in terms of safety, quality, and efficacy to an existing therapeutic drug. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. They are almost identical to an existing therapeutic drugs and can only be manufactured when the patent for the original innovator drug expires. Remicade biosimilars are used for the treatment of various autoimmune diseases such as ankylosing spondylitis, psoriatic arthritis, chronic severe plaque psoriasis, ulcerative colitis, Crohn's Disease, rheumatoid arthritis, etc. The number of biosimilars currently approved by the FDA is twenty-eight. Market Dynamics Increasing demand for biosimilar drugs and increasing incidence/prevalence of autoimmune diseases such as rheumatoid arthritis and plaque psoriasis is expected to propel the remicade biosimilar market growth. For instance, more than 24 people in the United States (more than ...